Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Early administration of oral oseltamivir increases the benefits of influenza treatment.

Aoki FY, Macleod MD, Paggiaro P, Carewicz O, El Sawy A, Wat C, Griffiths M, Waalberg E, Ward P; IMPACT Study Group.

J Antimicrob Chemother. 2003 Jan;51(1):123-9.

PMID:
12493796
2.

Oral oseltamivir treatment of influenza in children.

Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, Ipe D, Mills RG, Ward P.

Pediatr Infect Dis J. 2001 Feb;20(2):127-33. Erratum in: Pediatr Infect Dis J 2001 Apr;20(4):421.

PMID:
11224828
3.

Oral oseltamivir improves pulmonary function and reduces exacerbation frequency for influenza-infected children with asthma.

Johnston SL, Ferrero F, Garcia ML, Dutkowski R.

Pediatr Infect Dis J. 2005 Mar;24(3):225-32.

PMID:
15750458
4.

A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.

Kawai N, Ikematsu H, Iwaki N, Maeda T, Satoh I, Hirotsu N, Kashiwagi S.

Clin Infect Dis. 2006 Aug 15;43(4):439-44. Epub 2006 Jun 26.

PMID:
16838232
5.
6.

A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population.

Lin JT, Yu XZ, Cui DJ, Chen XY, Zhu JH, Wang YZ, Wu XD.

Curr Med Res Opin. 2006 Jan;22(1):75-82.

PMID:
16393433
7.

Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment.

Gillissen A, Höffken G.

Med Microbiol Immunol. 2002 Dec;191(3-4):165-8. Epub 2002 Sep 12. Review.

PMID:
12458353
8.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
9.

Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.

Kawai N, Ikematsu H, Iwaki N, Satoh I, Kawashima T, Maeda T, Miyachi K, Hirotsu N, Shigematsu T, Kashiwagi S.

Clin Infect Dis. 2005 May 1;40(9):1309-16. Epub 2005 Mar 16.

PMID:
15825034
10.

[A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population].

Lin JT, Yu XZ, Cui DJ, Chen XY, Zhu JH, Wang YZ, Wu XD, Gao H, Huo ZL, Zhu SH, Hu SL, Wang AX.

Zhonghua Jie He He Hu Xi Za Zhi. 2004 Jul;27(7):455-9. Chinese.

PMID:
15312558
11.

[A multicenter study of efficacy and safety of oseltamivir in the treatment of suspected influenza patients].

Deng WW, Li QY, Zhong NS; "Oseltamivir in the treatment of suspected influenza patients" Study Group.

Zhonghua Yi Xue Za Zhi. 2004 Dec 17;84(24):2132-6. Chinese.

PMID:
15730636
12.

Oral oseltamivir in human experimental influenza B infection.

Hayden FG, Jennings L, Robson R, Schiff G, Jackson H, Rana B, McClelland G, Ipe D, Roberts N, Ward P.

Antivir Ther. 2000 Sep;5(3):205-13.

PMID:
11075941
14.

Treatment and prevention of influenza: Swedish recommendations.

Uhnoo I, Linde A, Pauksens K, Lindberg A, Eriksson M, Norrby R; Swedish Consensus Group.

Scand J Infect Dis. 2003;35(1):3-11. Review.

PMID:
12685876
15.

A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.

Kawai N, Ikematsu H, Iwaki N, Maeda T, Kanazawa H, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Nagai T, Horii S, Hirotsu N, Kashiwagi S.

J Infect. 2008 Jan;56(1):51-7. Epub 2007 Oct 15.

PMID:
17936910
16.

Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.

Kawai N, Ikematsu H, Iwaki N, Kawashima T, Maeda T, Mitsuoka S, Kondou K, Satoh I, Miyachi K, Yamaga S, Shigematsu T, Hirotsu N, Kashiwagi S.

J Infect. 2007 Sep;55(3):267-72. Epub 2007 Jul 2.

PMID:
17604839
17.

Factors associated with early hospital discharge of adult influenza patients.

Lee N, Chan PK, Choi KW, Lui G, Wong B, Cockram CS, Hui DS, Lai R, Tang JW, Sung JJ.

Antivir Ther. 2007;12(4):501-8.

PMID:
17668558
18.

Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection.

Sugaya N, Ohashi Y.

Antimicrob Agents Chemother. 2010 Jun;54(6):2575-82. doi: 10.1128/AAC.01755-09. Epub 2010 Apr 5.

19.

Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.

Sugaya N, Tamura D, Yamazaki M, Ichikawa M, Kawakami C, Kawaoka Y, Mitamura K.

Clin Infect Dis. 2008 Aug 1;47(3):339-45. doi: 10.1086/589748.

PMID:
18582202
20.

Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children.

Kubo T, Nishimura H.

Phytomedicine. 2007 Feb;14(2-3):96-101. Epub 2006 Dec 1.

PMID:
17141491

Supplemental Content

Support Center